PulseSight Therapeutics SAS, an ophthalmology biotech company developing disruptive non-viral vectorized therapies with minimally-invasive delivery technology, is pleased to announce that the first ...

First-in-human administration of CPV-104 marks a major step in drug development for the company's lead compound (Factor H) and in bringing a new ...

Broadcom's AI momentum drives strong growth with custom accelerators, VMware integration, and inference demand. Read why AVGO ...

QQQ is a top AI and tech play, with strong momentum in AI spending driving future earnings and FCF growth for America's ...

The U.S. stock market is entering the second half of 2025 with significant momentum. After a volatile start to the year, ...

Nvidia stock has surged again, reaching all-time highs and making it one of the most highly valued companies in history. Dr James Fox thinks it could go higher. The post Here’s why Nvidia stock could ...

Advanced Micro Devices (NASDAQ: AMD), and other semiconductor stocks. To learn more, check out the short video, consider ...

In today's video, I discuss recent updates impacting Advanced Micro Devices (NASDAQ: AMD). To learn more, check out the short ...

Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) is the largest company in the stock market not in the technology sector. As of this writing, the conglomerate led by Warren Buffett had a market cap of ...

Aldeyra's Reproxalap progresses towards FDA approval, with a potential $100M AbbVie deal. There’s still upside potential, ...

D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment ...

US Stock futures rise slightly after a weak tech-led start to the second half of 2025, offering signs of investor caution but ...